This is a prospective , randomized , active-controlled , PROBE design study in @ patients ( @ @ years , @ % men ) with mild-to-moderate hypertension and type @ diabetes , with normal ejection fraction , randomized to either indapamide ( @ mg Slow Release ( SR ) / day ) or hydrochlorothiazide ( @ mg/d ) , added to quinapril ( @-@ mg/d ) .